Quote | Galecto Inc. (NASDAQ:GLTO)
Last: | $0.78 |
---|---|
Change Percent: | 0.0% |
Open: | $0.7745 |
Close: | $0.78 |
High: | $0.8199 |
Low: | $0.7745 |
Volume: | 129,262 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Galecto Inc. (NASDAQ:GLTO)
2024-03-15 13:53:13 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galecto (NASDAQ: GLTO ) just reported results for the fourth quarter of 2023. Galecto reported earnings per share of -22 cents. This was above the analyst estimate for EPS...
2023-12-21 16:40:39 ET More on Galecto Galecto reduces workforce by 70%, explores potential strategic alternatives Seeking Alpha’s Quant Rating on Galecto Historical earnings data for Galecto Financial information for Galecto For further detail...
Message Board Posts | Galecto Inc. (NASDAQ:GLTO)
Subject | By | Source | When |
---|---|---|---|
znewcar1: Established: 08/16/2021 5:14:57 PM Last Post: 06/03/2022 4:17:16 PM Read More: https://inv | znewcar1 | investorshangout | 06/03/2022 8:17:45 PM |
znewcar1: GLTO 35% v1,8M c1.96 f25,26M H2.10 morning pop and held VWAP near EOD push w/ vol. | znewcar1 | investorshangout | 06/03/2022 8:17:16 PM |
News, Short Squeeze, Breakout and More Instantly...
Galecto Inc. Company Name:
GLTO Stock Symbol:
NASDAQ Market:
With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: NIKE, Inc. (NYS...
BOSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced positive topline results from a Phase 2a trial of GB2064 for the treatment of myelofibrosis (the &...